Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by B. Riley Wealth Advisors Inc.

B. Riley Wealth Advisors Inc. lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 22.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,097 shares of the biotechnology company's stock after selling 896 shares during the period. B. Riley Wealth Advisors Inc.'s holdings in Axon Enterprise were worth $1,841,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the business. Mutual Advisors LLC purchased a new position in Axon Enterprise during the 4th quarter valued at $333,000. Brighton Jones LLC bought a new stake in shares of Axon Enterprise during the fourth quarter worth $480,000. Cornerstone Wealth Management LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter valued at $260,000. Geneos Wealth Management Inc. grew its holdings in shares of Axon Enterprise by 630.0% in the fourth quarter. Geneos Wealth Management Inc. now owns 1,847 shares of the biotechnology company's stock worth $1,098,000 after purchasing an additional 1,594 shares during the last quarter. Finally, Linden Thomas Advisory Services LLC increased its stake in Axon Enterprise by 20.5% in the 4th quarter. Linden Thomas Advisory Services LLC now owns 910 shares of the biotechnology company's stock worth $541,000 after buying an additional 155 shares during the period. Institutional investors own 79.08% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on AXON shares. Needham & Company LLC lifted their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. Barclays boosted their price target on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Finally, JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Axon Enterprise has an average rating of "Moderate Buy" and an average target price of $652.73.

Insider Buying and Selling at Axon Enterprise

In other news, Director Jeri Williams sold 307 shares of the firm's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares of the company's stock, valued at $899,275.44. This trade represents a 15.87% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 34,969 shares of company stock worth $23,127,314 over the last three months. Corporate insiders own 5.70% of the company's stock.

Axon Enterprise Stock Down 2.8%

Shares of AXON traded down $20.71 during trading hours on Thursday, hitting $730.29. The company had a trading volume of 535,350 shares, compared to its average volume of 737,094. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $755.05. The company's fifty day moving average price is $614.09 and its two-hundred day moving average price is $608.69. The company has a market capitalization of $56.85 billion, a PE ratio of 188.71, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The business had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same period in the previous year, the company posted $1.15 earnings per share. The firm's revenue was up 31.3% on a year-over-year basis. As a group, equities analysts forecast that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.